These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1657804)

  • 1. Oxytocin antagonists with changes in the Asn5 position shed light on hormone-oxytocin receptor interactions.
    Hill PS; Chan WY; Hruby VJ
    Int J Pept Protein Res; 1991 Jul; 38(1):32-7. PubMed ID: 1657804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting oxytocin antagonists: effects of 2-D-stereoisomer substitution on antagonistic potency and duration of action.
    Chan WY; Rockway TW; Hruby VJ
    Proc Soc Exp Biol Med; 1987 Jun; 185(2):187-92. PubMed ID: 3575333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of oxytocin antagonists with prolonged action: potential tocolytic agents for the treatment of preterm labor.
    Chan WY; Hruby VJ; Rockway TW; Hlavacek J
    J Pharmacol Exp Ther; 1986 Oct; 239(1):84-7. PubMed ID: 3761199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isosteric substitution of Asn5 in antagonists of oxytocin and vasopressin leads to highly selective and potent oxytocin and V1a receptor antagonists: new approaches for the design of potential tocolytics for preterm labor.
    Chan WY; Wo NC; Cheng LL; Manning M
    J Pharmacol Exp Ther; 1996 May; 277(2):999-1003. PubMed ID: 8627583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of highly selective in vitro and in vivo uterine receptor antagonists of oxytocin: comparisons with Atosiban.
    Manning M; Miteva K; Pancheva S; Stoev S; Wo NC; Chan WY
    Int J Pept Protein Res; 1995; 46(3-4):244-52. PubMed ID: 8537178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural requirements of the oxytocin receptor in rat uterus. Free-Wilson analysis in a series of competitive oxytocin inhibitors.
    Pliska V; Heiniger J
    Int J Pept Protein Res; 1988 Jun; 31(6):520-36. PubMed ID: 2842268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analogues of a potent oxytocin antagonist with truncated C-terminus or shorter amino acid side chain of the basic amino acid at position 8.
    Flouret G; Chaloin O; Slaninová J
    J Pept Sci; 2003 Jun; 9(6):393-401. PubMed ID: 12846485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of novel bicyclic analogues derived from a potent oxytocin antagonist.
    Flouret G; Chaloin O; Borovickova L; Slaninová J
    J Pept Sci; 2006 Jun; 12(6):412-9. PubMed ID: 16432806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and some pharmacological properties of two new antagonists of oxytocin.
    Rekowski P; Melin P; Lammek B
    Pol J Pharmacol Pharm; 1987; 39(3):303-7. PubMed ID: 3438212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of inactivation of oxytocin receptor and inhibition of prostaglandin synthesis on uterine oxytocin receptor and gap junction formation and labor in the rat.
    Chan WY; Berezin I; Daniel EE; Russell KC; Hruby VJ
    Can J Physiol Pharmacol; 1991 Sep; 69(9):1262-7. PubMed ID: 1661637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological activity of oxytocin analogues containing conformationally-restricted residues in position 7.
    Fragiadaki M; Magafa V; Borovicková L; Slaninová J; Cordopatis P
    Eur J Med Chem; 2007 Jun; 42(6):799-806. PubMed ID: 17316912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-D- phenylalanine,4-valine]arginine-vasopressin at position 4.
    Manning M; Olma A; Klis WA; Seto J; Sawyer WH
    J Med Chem; 1983 Nov; 26(11):1607-13. PubMed ID: 6631916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-phase synthesis of 16 potent (selective and nonselective) in vivo antagonists of oxytocin.
    Manning M; Kruszynski M; Bankowski K; Olma A; Lammek B; Cheng LL; Klis WA; Seto J; Haldar J; Sawyer WH
    J Med Chem; 1989 Feb; 32(2):382-91. PubMed ID: 2913298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic antagonists of in vivo responses by the rat uterus to oxytocin.
    Lowbridge J; Manning M; Seto J; Haldar J; Sawyer WH
    J Med Chem; 1979 May; 22(5):565-9. PubMed ID: 458806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is oxytocin-induced grooming mediated by uterine-like receptors?
    Caldwell JD; Hruby VJ; Hill P; Prange AJ; Pedersen CA
    Neuropeptides; 1986 Jul; 8(1):77-86. PubMed ID: 3020470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An oxytocin receptor in anococcygeus muscles isolated from male mice.
    Gibson A
    Br J Pharmacol; 1986 May; 88(1):155-9. PubMed ID: 3011170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterotonic activity and myometrial receptor affinity of 1-deamino-1-carba-2-tyrosine(O-methyl)-oxytocin.
    Atke A; Vilhardt H
    Acta Endocrinol (Copenh); 1987 May; 115(1):155-60. PubMed ID: 3035851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of oxytocin-induced but not angiotensin-induced rat uterine contractions following exposure to sodium sulfide.
    Hayden LJ; Franklin KJ; Roth SH; Moore GJ
    Life Sci; 1989; 45(26):2557-60. PubMed ID: 2559275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of oxytocin antagonists, which are more selective than atosiban.
    Manning M; Stoev S; Cheng LL; Wo NC; Chan WY
    J Pept Sci; 2001 Sep; 7(9):449-65. PubMed ID: 11587184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic substitution of an oxytocin antagonist with D-amino acids: unexpected high antagonistic potency of the D-Cys6-substituted analogue.
    Flouret G; Majewski T; Brieher W; Wilson L
    J Med Chem; 1993 Mar; 36(6):747-9. PubMed ID: 8459401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.